Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120).

Authors: Zukin, Mauro, Gondim, Victor, Shimada, Andrea Kazumi, e Abreu Lima, Ellias Magalhães, Mathias, Clarissa, Fernandes Barra, Williams, William Junior, William Nassib, Padoan, Mônica, Bittencourt, Yuri, Yamamura, Rosely, Baston Silva, Carlos Eduardo, de Jesus Rossato, Letícia, de Almeida Monteiro, Caio, Gomes de Jesus, Rafaela, Gössling, Gustavo, Zimmer Gelatti, Ana Caroline

Source: Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia; Nov/Dec2024, Vol. 50 Issue 6, p1-9, 9p

Subject Terms: PATIENT compliance, NON-small-cell lung carcinoma, ADVERSE health care events, OVERALL survival, PROGRESSION-free survival

Geographic Terms: BRAZIL